Allphin; Clark P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Allphin; Clark P..The latest application filed is for "gamma-hydroxybutyrate compositions and their uses for the treatment of disorders".

Company Profile

5.8.15

Allphin; Clark P. - Seattle WA
Allphin; Clark P. - Los Altos CA
Allphin; Clark P. - Mountain View CA
Allphin; Clark P. - Concord CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Grant 11,426,373 - Allphin , et al. August 30, 2	2022-08-30
Gamma-hydroxybutyrate Compositions And Their Uses For The Treatment Of Disorders App 20220000815 - Allphin; Clark P. ; et al.	2022-01-06
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20210121423 - Allphin; Clark P. ; et al.	2021-04-29
Gamma-hydroxybutyrate Compositions And Their Uses For The Treatment Of Disorders App 20200338029 - Allphin; Clark P. ; et al.	2020-10-29
Method of using gamma-hydroxybutyrate compositions for the treatment of disorders Grant 10,675,258 - Allphin , et al.	2020-06-09
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20200113853 - Allphin; Clark P. ; et al.	2020-04-16
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20190224149 - Allphin; Clark P. ; et al.	2019-07-25
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders Grant 10,195,168 - Allphin , et al. Fe	2019-02-05
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20180263936 - Allphin; Clark P. ; et al.	2018-09-20
Gamma-hydroxybutyrate Compositions And Their Uses For The Treatment Of Disorders App 20170209396 - Allphin; Clark P. ; et al.	2017-07-27
Methods of making a mixture of salts of gamma-hydroxybutyrate Grant 9,555,017 - Allphin , et al. January 31, 2	2017-01-31
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20160058720 - Allphin; Clark P. ; et al.	2016-03-03
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Grant 9,132,107 - Allphin , et al. September 15, 2	2015-09-15
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Grant 8,901,173 - Allphin , et al. December 2, 2	2014-12-02
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20140171505 - Allphin; Clark P. ; et al.	2014-06-19
Gamma-hydroxybutyrate Compositions And Their Use For The Treatment Of Disorders App 20140171506 - Allphin; Clark P. ; et al.	2014-06-19
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Grant 8,591,922 - Allphin , et al. November 26, 2	2013-11-26
Means of delivering drugs in an ascending zero order release pattern App 20060034927 - Casadevall; Gemma ; et al.	2006-02-16
Stepwise delivery of topiramate over prolonged period of time App 20050136108 - Yam, Noymi V. ; et al.	2005-06-23
Therapeutic composition and delivery system for administering drug App 20040062799 - Ayer, Atul D. ; et al.	2004-04-01
Methods and dosage forms for controlled delivery of oxycodone App 20040010000 - Ayer, Atul D. ; et al.	2004-01-15
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone App 20030224051 - Fink, Tracy A. ; et al.	2003-12-04
Pyridinecarboxylic acid chlorides from (trichloromethyl)pyridines Grant 5,166,352 - Allphin November 24, 1	1992-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.